Statement Of Cash Flows [Abstract]

ChemoMetec - Filing #1398588

Concept 2021-07-01 to
2022-06-30
As at
2022-06-30
2021-07-01 to
2022-06-30
As at
2021-07-01
2020-07-01 to
2021-06-30
As at
2021-06-30
2020-07-01 to
2021-06-30
2020-07-01 to
2021-06-30
As at
2020-07-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
159,469 DKK
159,469 DKK
88,354 DKK
18,744 DKK
69,610 DKK
Adjustments to reconcile profit (loss) [abstract]
Adjustments for depreciation and amortisation expense
20,038 DKK
19,607 DKK
Interest paid, classified as operating activities
1,518 DKK
918,000 DKK
Interest received, classified as operating activities
9,000 DKK
88,000 DKK
Income taxes paid (refund), classified as operating activities
27,634 DKK
16,569 DKK
Cash flows from (used in) operating activities
176,860 DKK
107,901 DKK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
39,101 DKK
11,249 DKK
Purchase of intangible assets, classified as investing activities
16,815 DKK
13,373 DKK
Cash flows from (used in) investing activities
56,046 DKK
24,683 DKK
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
433,000 DKK
168,000 DKK
Payments of lease liabilities, classified as financing activities
1,729 DKK
854,000 DKK
Dividends paid, classified as financing activities
69,610 DKK
26,104 DKK
Other inflows (outflows) of cash, classified as financing activities
1,895 DKK
Cash flows from (used in) financing activities
69,012 DKK
26,037 DKK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
51,802 DKK
57,181 DKK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
7,114 DKK
4,013 DKK
Cash and cash equivalents
209,025 DKK
150,109 DKK
150,109 DKK
96,941 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.